Concentrix (NASDAQ:CNXC) Raised to “Buy” at Wall Street Zen

Concentrix (NASDAQ:CNXCGet Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

A number of other brokerages also recently issued reports on CNXC. Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Robert W. Baird set a $52.00 target price on shares of Concentrix in a report on Wednesday, January 14th. Finally, Barrington Research reissued an “outperform” rating and set a $62.00 price target on shares of Concentrix in a report on Monday, January 12th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $63.75.

Get Our Latest Analysis on CNXC

Concentrix Trading Up 0.5%

Shares of Concentrix stock opened at $30.39 on Friday. The stock has a market cap of $1.87 billion, a PE ratio of -1.46, a price-to-earnings-growth ratio of 0.32 and a beta of 0.50. The firm has a fifty day moving average price of $40.16 and a 200 day moving average price of $43.65. Concentrix has a 1 year low of $29.35 and a 1 year high of $66.00. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40.

Concentrix (NASDAQ:CNXCGet Free Report) last announced its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.93 by $0.02. The company had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period last year, the firm earned $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Equities research analysts predict that Concentrix will post 10.11 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Christopher A. Caldwell acquired 1,000 shares of the firm’s stock in a transaction on Thursday, January 29th. The shares were acquired at an average cost of $37.07 per share, with a total value of $37,070.00. Following the completion of the acquisition, the chief executive officer directly owned 362,075 shares in the company, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of CNXC. Kestra Advisory Services LLC acquired a new stake in Concentrix in the 4th quarter worth about $100,000. Marshall Wace LLP lifted its position in shares of Concentrix by 1,062.2% in the fourth quarter. Marshall Wace LLP now owns 394,686 shares of the company’s stock valued at $16,411,000 after acquiring an additional 360,725 shares in the last quarter. Stifel Financial Corp boosted its stake in shares of Concentrix by 2.2% in the fourth quarter. Stifel Financial Corp now owns 153,062 shares of the company’s stock worth $6,364,000 after acquiring an additional 3,265 shares during the last quarter. Advyzon Investment Management LLC acquired a new stake in shares of Concentrix in the fourth quarter worth approximately $341,000. Finally, First Trust Advisors LP increased its position in shares of Concentrix by 37.7% during the fourth quarter. First Trust Advisors LP now owns 805,898 shares of the company’s stock worth $33,509,000 after purchasing an additional 220,590 shares in the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.

About Concentrix

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Featured Stories

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.